Aquaporins in Renal Diseases (Q61815142)

12 December 2020

Reduced water permeability and altered ultrastructure in thin descending limb of Henle in aquaporin-1 null mice

1 reference

12 December 2020

Nephrogenic diabetes insipidus in mice lacking aquaporin-3 water channels.

1 reference

12 December 2020

Neonatal mortality in an aquaporin-2 knock-in mouse model of recessive nephrogenic diabetes insipidus

1 reference

12 December 2020

Erythrocyte water permeability and renal function in double knockout mice lacking aquaporin-1 and aquaporin-3

1 reference

12 December 2020

Regulation of AQP6 mRNA and protein expression in rats in response to altered acid-base or water balance

1 reference

12 December 2020

Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects

1 reference

12 December 2020

Aquaporin gene delivery to kidney

1 reference

12 December 2020

Altered expression of aquaporin-2 in human explants with chronic renal allograft dysfunction

1 reference

12 December 2020

Urinary aquaporin-2 in children with acute pyelonephritis.

1 reference

12 December 2020

Mouse model of inducible nephrogenic diabetes insipidus produced by floxed aquaporin-2 gene deletion

1 reference

12 December 2020

Correlation Between AVPR2 Mutations and Urinary AQP2 Excretion in Patients with Nephrogenic Diabetes Insipidus

1 reference

12 December 2020

Role of AQP1 in endotoxemia-induced acute kidney injury

1 reference

12 December 2020

Hsp90 inhibitor partially corrects nephrogenic diabetes insipidus in a conditional knock-in mouse model of aquaporin-2 mutation

1 reference

12 December 2020

Aquaporin water channels in mammals

1 reference

12 December 2020

1 reference

12 December 2020

Inhibition of NF-kappaB ameliorates sepsis-induced downregulation of aquaporin-2/V2 receptor expression and acute renal failure in vivo

1 reference

12 December 2020

1 reference

12 December 2020

GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity

1 reference

12 December 2020

Aquaporins in kidney pathophysiology

1 reference

12 December 2020

The changes of aquaporin 2 in the graft of acute rejection rat renal transplantation model.

1 reference

12 December 2020

Aquaporin-3 mediates hydrogen peroxide uptake to regulate downstream intracellular signaling

1 reference

12 December 2020

Adenylate cyclase 6 determines cAMP formation and aquaporin-2 phosphorylation and trafficking in inner medulla

1 reference

12 December 2020

Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control

1 reference

12 December 2020

Altered urinary excretion of aquaporin 2 in IgA nephropathy

1 reference

12 December 2020

Expression of aquaporin-1, -2 and -4 in mice with a spontaneous mutation leading to hydronephrosis

1 reference

12 December 2020

Renal ischaemia/reperfusion injury: possible role of aquaporins.

1 reference

12 December 2020

AQP5 is expressed in type-B intercalated cells in the collecting duct system of the rat, mouse and human kidney.

1 reference

12 December 2020

In mpkCCD cells, long-term regulation of aquaporin-2 by vasopressin occurs independent of protein kinase A and CREB but may involve Epac

1 reference

12 December 2020

Sepsis-induced urinary concentration defect is related to nitric oxide-dependent inactivation of TonEBP/NFAT5, which downregulates renal medullary solute transport proteins and aquaporin-2.

1 reference

12 December 2020

Aqp5 is a new transcriptional target of Dot1a and a regulator of Aqp2.

1 reference

12 December 2020

Aquaporin 11 insufficiency modulates kidney susceptibility to oxidative stress.

1 reference

12 December 2020

Renal aquaporins and water balance disorders

1 reference

12 December 2020

Specific aquaporins facilitate Nox-produced hydrogen peroxide transport through plasma membrane in leukaemia cells

1 reference

12 December 2020

Aquaporins: important but elusive drug targets.

1 reference

12 December 2020

Alpha-lipoic acid attenuates lipopolysaccharide-induced kidney injury

1 reference

12 December 2020

Aberrant glycosylation and localization of polycystin-1 cause polycystic kidney in an AQP11 knockout model

1 reference

12 December 2020

Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer

1 reference

12 December 2020

Aquaporin-1 retards renal cyst development in polycystic kidney disease by inhibition of Wnt signaling

1 reference

12 December 2020

Diabetic nephropathy and proximal tubular damage

1 reference

12 December 2020

A novel therapeutic effect of statins on nephrogenic diabetes insipidus

1 reference

12 December 2020

Aliskiren restores renal AQP2 expression during unilateral ureteral obstruction by inhibiting the inflammasome

1 reference

12 December 2020

The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease

1 reference

12 December 2020

Decrease of phosphorylated proto-oncogene CREB at Ser 133 site inhibits growth and metastatic activity of renal cell cancer

1 reference

12 December 2020

Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus.

1 reference

12 December 2020

Aquaporin-3-mediated hydrogen peroxide transport is required for NF-κB signalling in keratinocytes and development of psoriasis

1 reference

12 December 2020

Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts

1 reference

12 December 2020

Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study

1 reference

12 December 2020

Urinary Biomarkers for the Detection and Management of Localized Renal Cell Carcinoma

1 reference

12 December 2020

Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis

1 reference

12 December 2020

NSAIDs Alter Phosphorylated Forms of AQP2 in the Inner Medullary Tip.

1 reference

12 December 2020

Autophagic degradation of aquaporin-2 is an early event in hypokalemia-induced nephrogenic diabetes insipidus

1 reference

12 December 2020

Water, Water Everywhere: A New Cause and a New Treatment for Nephrogenic Diabetes Insipidus

1 reference

12 December 2020

Aquaporin 11 variant associates with kidney disease in type 2 diabetic patients

1 reference

12 December 2020

Aquaporin-9 facilitates membrane transport of hydrogen peroxide in mammalian cells

1 reference

12 December 2020

Aquaporin-2 is a potential biomarker for tolvaptan efficacy in decompensated heart failure complicated by diabetic nephrotic syndrome

1 reference

12 December 2020

Autoantibodies Targeting a Collecting Duct-Specific Water Channel in Tubulointerstitial Nephritis.

1 reference

12 December 2020

Urine AQP5 is a potential novel biomarker of diabetic nephropathy

1 reference

12 December 2020

Phosphatase inhibition increases AQP2 accumulation in the rat IMCD apical plasma membrane

1 reference

12 December 2020

Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.

1 reference

12 December 2020

Aquaporin modulators: a patent review (2010-2015).

1 reference

12 December 2020

EGF Receptor Inhibition by Erlotinib Increases Aquaporin 2-Mediated Renal Water Reabsorption

1 reference

12 December 2020

Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway.

1 reference

12 December 2020

Enhanced Autophagy in Polycystic Kidneys of AQP11 Null Mice

1 reference

12 December 2020

Hypercalcemia induces targeted autophagic degradation of aquaporin-2 at the onset of nephrogenic diabetes insipidus

1 reference

12 December 2020

L-Carnitine Ameliorates the Decrease of Aquaporin 2 Levels in Rats with Cisplatin-Induced Kidney Injury

1 reference

12 December 2020

Aliskiren increases aquaporin-2 expression and attenuates lithium-induced nephrogenic diabetes insipidus.

1 reference

12 December 2020

Hyperactivation of Nrf2 in early tubular development induces nephrogenic diabetes insipidus.

1 reference

12 December 2020

Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy.

1 reference

12 December 2020

Transport Characteristics of Aquaporins

1 reference

12 December 2020

Aquaporins in Urinary System

1 reference

12 December 2020

Aquaporin-3 deletion in mice results in renal collecting duct abnormalities and worsens ischemia-reperfusion injury

1 reference

12 December 2020

Severe acute dehydration in a desert rodent elicits a transcriptional response that effectively prevents kidney injury

1 reference

12 December 2020

Genetics of Diabetes Insipidus

1 reference

12 December 2020

Hepatocyte Nuclear Factor-1β Regulates Urinary Concentration and Response to Hypertonicity

1 reference

12 December 2020

Integrin-Linked Kinase Signaling Promotes Cyst Growth and Fibrosis in Polycystic Kidney Disease

1 reference

12 December 2020

Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease

1 reference

12 December 2020

Integrin linked kinase regulates the transcription of AQP2 by NFATC3.

1 reference

12 December 2020

New treatment paradigms for ADPKD: moving towards precision medicine

1 reference

12 December 2020

Manganese promotes intracellular accumulation of AQP2 via modulating F-actin polymerization and reduces urinary concentration in mice

1 reference

12 December 2020

Proteomic analysis of AQP11-null kidney: Proximal tubular type polycystic kidney disease

1 reference

12 December 2020

The potential role of aquaporin 1 on aristolochic acid I induced epithelial mesenchymal transition on HK-2 cells.

1 reference

12 December 2020

Targeting renal fibrosis: Mechanisms and drug delivery systems.

1 reference

12 December 2020

Polycystic kidney disease: Tolvaptan slows disease progression in late-stage ADPKD.

1 reference

12 December 2020

Characterization of urinary exosomal release of aquaporin-1 and -2 after renal ischemia-reperfusion in rats.

1 reference

12 December 2020

Steviol slows renal cyst growth by reducing AQP2 expression and promoting AQP2 degradation.

1 reference

12 December 2020

Genome-Wide Mapping of DNA Accessibility and Binding Sites for CREB and C/EBPβ in Vasopressin-Sensitive Collecting Duct Cells.

1 reference

12 December 2020

Effects of cholecalciferol cholesterol emulsion on renal fibrosis and aquaporin 2 and 4 in mice with unilateral ureteral obstruction

1 reference

12 December 2020

Hydrogen Sulfide Attenuates LPS-Induced Acute Kidney Injury by Inhibiting Inflammation and Oxidative Stress.

1 reference

12 December 2020

AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus.

1 reference

12 December 2020

Tolvaptan: Clinical Evidence for Slowing the Progression of Autosomal Dominant Polycystic Kidney Disease

1 reference

12 December 2020

Aquaporin 11 rs2276415 variant and progression of chronic kidney disease

1 reference

12 December 2020

Hydrogen sulfide upregulates renal AQP-2 protein expression and promotes urine concentration

1 reference

12 December 2020

Metabolism and mitochondria in polycystic kidney disease research and therapy

1 reference

12 December 2020

Bile Acid G Protein-Coupled Membrane Receptor TGR5 Modulates Aquaporin 2-Mediated Water Homeostasis

1 reference

12 December 2020

1 reference

12 December 2020

Excretion of Urinary Metabolites of the Phthalate Esters DEP and DEHP in 16 Volunteers after Inhalation and Dermal Exposure

1 reference

12 December 2020

Nephrogenic Diabetes Insipidus

1 reference

12 December 2020

Urinary aquaporin 1 and perilipin 2: Can these novel markers accurately characterize small renal masses and help guide patient management?

1 reference

12 December 2020